Viewing Study NCT04678102

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:54 AM
Ignite Modification Date: 2026-04-22 @ 10:25 PM
Study NCT ID: NCT04678102
Status: UNKNOWN
Last Update Posted: 2023-06-26
First Post: 2020-11-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Chk2 Inhibitor for Recurrent EpitheliAl periToneal, fallopIan or oVarian cancEr (CREATIVE Phase IA Trial)
Sponsor: Seoul National University Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Platinum-resistant Ovarian Cancer View
None Platinum-refractory Ovarian Carcinoma View
None Platinum-Resistant Fallopian Tube Carcinoma View
None Platinum-Resistant Primary Peritoneal Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PHI-101 View
None Chk2 inhibitor View
None antineoplastic View
None Platinum-resistant Ovarian Cancer View